|
gptkbp:instance_of
|
gptkb:Scientist
|
|
gptkbp:affiliation
|
gptkb:Weill_Cornell_Medical_College
|
|
gptkbp:award
|
gptkb:National_Medal_of_Science
|
|
gptkbp:birth_date
|
1953-01-01
|
|
gptkbp:birth_place
|
gptkb:Massachusetts,_USA
|
|
gptkbp:children
|
2
|
|
gptkbp:contribution
|
apoptosis
cellular metabolism
clinical trials
signal transduction
pharmacology
biomedical research
genomics
tumorigenesis
targeted therapy
tumor microenvironment
therapeutic development
translational research
proteomics
precision medicine
insulin signaling
metabolomics
biomarkers for cancer
cancer immunotherapy
cancer diagnostics
cell survival pathways
metabolic reprogramming
therapeutic targets in cancer
molecular mechanisms of cancer
drug resistance in cancer
cell growth regulation
understanding cancer metabolism
|
|
gptkbp:education
|
gptkb:University_of_California,_Berkeley
|
|
gptkbp:fellowship
|
gptkb:American_Academy_of_Arts_and_Sciences
gptkb:American_Association_for_the_Advancement_of_Science
gptkb:National_Academy_of_Sciences
|
|
gptkbp:field
|
cancer research
|
|
gptkbp:honors
|
gptkb:Gairdner_Foundation_International_Award
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dr. Lewis Cantley
|
|
gptkbp:influenced
|
cancer therapy development
|
|
gptkbp:influenced_by
|
gptkb:Harold_Varmus
|
|
gptkbp:invention
|
PI3 K inhibitors
|
|
gptkbp:known_for
|
discovering the phosphoinositide 3-kinase (PI3 K) pathway
|
|
gptkbp:nationality
|
gptkb:American
|
|
gptkbp:notable_work
|
PI3 K signaling in cancer
|
|
gptkbp:publication
|
gptkb:Nature
gptkb:Cancer_Cell
gptkb:Journal_of_Biological_Chemistry
gptkb:Science
gptkb:Cell
|
|
gptkbp:research_areas
|
molecular biology
|
|
gptkbp:research_focus
|
cell signaling
|
|
gptkbp:research_institutes
|
gptkb:Weill_Cornell_Medicine
|
|
gptkbp:spouse
|
Dr. Susan Cantley
|
|
gptkbp:bfsParent
|
gptkb:The_Weill_Center_for_Cancer_Research
|
|
gptkbp:bfsLayer
|
7
|